@prefix orcid: <https://orcid.org/> .
@prefix this: <http://purl.org/np/RATUWXtg7ElfHZzjOAIRoz6i1H_2YStYZEwcuW2zuiV5w> .
@prefix sub: <http://purl.org/np/RATUWXtg7ElfHZzjOAIRoz6i1H_2YStYZEwcuW2zuiV5w#> .
@prefix np: <http://www.nanopub.org/nschema#> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix ns2: <http://twoc-nlp-database-server-1:8555/solr/triples/select?fl=TRIPLE_UID,%20CORD_UID,%20SUBJECT,%20PREDICATE,%20WORDNET_SEMREL,%20%20OBJECT,%20PRED_POSITION,%20SUBJECT_CUIS,%20OBJECT_CUIS,%20UMLS_SEMREL,%20PRED_POSITION,%20PREDICATE-LEMMA&q=CORD_UID:3uitj0kw&rows=> .
@prefix ns1: <http://wordnet-rdf.princeton.edu/lemma/> .
@prefix prov: <http://www.w3.org/ns/prov#> .
@prefix ns3: <http://twoc-nlp-database-server-1:8555/solr/triples/select?q=TRIPLE_UID:> .
@prefix npx: <http://purl.org/nanopub/x/> .
sub:Head {
  this: np:hasAssertion sub:assertion ;
    np:hasProvenance sub:provenance ;
    np:hasPublicationInfo sub:pubInfo ;
    a np:Nanopublication .
}
sub:assertion {
  <https://uts.nlm.nih.gov/uts/umls/concept/C0392920> ns1:associate <https://uts.nlm.nih.gov/uts/umls/concept/C0030705> .
}
sub:provenance {
  sub:assertion prov:generatedAtTime "2021-12-16T20:03:51.724720"^^xsd:dateTime ;
    prov:wasGeneratedBy "S&T TWOC project version 2" .
  sub:version prov:value 2 .
  rdf:OBJECT rdfs:label "with good outcomes among select patients with newly diagnosed or stage I / II NK / T-LAHLH" .
  rdf:OBJECT-POSITION rdfs:label 31 .
  rdf:PREDICATE rdfs:label "associated" .
  rdf:PREDICATE-POSITION rdfs:label "[229]" .
  rdf:SUBJECT rdfs:label "etoposide + dexamethasone-based chemotherapy regimens" .
  rdf:SUBJECT-POSITION rdfs:label 202 .
  rdfs:ABSTRACT-UID ns2:50 "3uitj0kw" .
  rdfs:SENTENCE rdfs:label "Although patients with hemophagocytic lymphohistiocytosis (NK)/T-LAHLH), which is a rare and fatal disease with no effective therapy generally experienced poor outcomes, etoposide + dexamethasone-based chemotherapy regimens were associated with good outcomes among select patients with newly diagnosed or stage I/II NK/T-LAHLH." .
  rdfs:TRIPLE-UID ns3:3uitj0kw-TRIPLE-ABSTRACT-19 "3uitj0kw-TRIPLE-ABSTRACT-19" .
  <https://uts.nlm.nih.gov/uts/umls/concept/C0030705> rdfs:label "patients" .
  <https://uts.nlm.nih.gov/uts/umls/concept/C0392920> rdfs:label "chemotherapy regimens" .
}
sub:pubInfo {
  sub:assertion prov:wasDerivedFrom <https://doi.org/10.1007/s00432-020-03376-7> .
  sub:sig npx:hasAlgorithm "RSA" ;
    npx:hasPublicKey "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCSLeezU8JYlBsrgXOGXX4fxOq4oydsMzMK1CN0Rez2OEd2IYk18R4DetcZXwGhN3Pil7qcgNkiGvTirJXIo8zHl7jVehs19EdYtrttCKEaXRzWIr4LuCrfGedkvonEMWqR8e1GdQsLgEEyM50BD6Qw+srQt9ozcqf/9wG2MAMX9QIDAQAB" ;
    npx:hasSignature "PO9Et3/bqDpeOfFcCCslAVozIqhnN3B9zmU7FhIoPeB7avhzBfsg8IvQzT2Gimq61un72T0V2FFie6Svpoe8LrrKCAvmOnYaaEbW+Ftbln/AL24B642CjvmC29t4AAqq8I1XWkFQYMmqb3g+nZA5LH5Ry78GOh18uiFDyx5fwws=" ;
    npx:hasSignatureTarget this: .
  this: prov:generatedAtTime "2021-12-16T20:03:51.724720"^^xsd:dateTime ;
    prov:wasAttributedTo orcid:0000-0002-8954-0470 .
}